Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion

Redox Report

Volumn 14, Issue 6, 2009, Pages 251-258

  Yamamoto, Yorihiro ^a   Yanagisawa, Makoto ^b   Tak, Nyou Wei ^b   Watanabe, Kazutoshi ^c   Takahashi, Chizuko ^c   Fujisawa, Akio ^a   Kashiba, Misato ^a   Tanaka, Masahiko ^c  

^a TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Antioxidant; Brain infarction; Free radical scavenger drug; Oxidative stress; Stearoyl coa desaturase

Indexed keywords

ACYL COENZYME A DESATURASE; ALPHA TOCOPHEROL; ASCORBIC ACID; FATTY ACID; NORPHENAZONE; OLEIC ACID; POLYUNSATURATED FATTY ACID; QUINONE DERIVATIVE; STEARIC ACID; UBIQUINONE 9; UNCLASSIFIED DRUG; URATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETREATMENT; TREATMENT DURATION; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; ANTIPYRINE; BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; FREE RADICAL SCAVENGERS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MOLECULAR STRUCTURE; NEUROPSYCHOLOGICAL TESTS; OLEIC ACID; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 73949107810     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/135100009X12525712409779     Document Type: Article

References (31)

1. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990; 21: 1086-1090.
2. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem1992; 59: 1609-1623.
3. Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). Redox Report 1996; 2: 333-338.
4. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003; 15: 222-229.
5. Watanabe K, Watanabe K, Kuwahara T, Yamamoto Y. Free radicalinduced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). J JpnOil ChemSoc 1997; 46: 797-801.
6. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988; 19: 480-485.
7. Shichinohe H, Kuroda S, Yasuda H et al. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 2004; 1029: 200-206.
8. ZhangN,Komine-KobayashiM, TanakaR, LiuM,MizunoY,Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005; 36: 2220-2225.
9. Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito K. Effects of a novel free radical scavenger,MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1997; 281: 921-927.
10. Bederson JB, Pitts LH, TsujiM, NishimuraMC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-486.
11. YamamotoY,Ames BN.Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay. Free Radic BiolMed 1987; 3: 359-361.
12. Yamashita S, Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem1997; 250: 66-73.
13. Yamamoto Y, Nagata Y, Katsurada M, Sato S, Ohori Y. Changes in rat plasma free fatty acids composition under oxidative stress induced by carbon tetrachloride: Decrease of polyunsaturated fatty acids and increase of palmitoleic acid. Redox Report 1996; 2: 121-125.
14. Yamamoto Y, Sone H, Yamashita S et al. Oxidative stress in LEC rats evaluated by plasma antioxidants and free fatty acids. J Trace Elem Exp Med 1997; 10: 129-134.
15. Yamamoto Y, Yamashita S, Fujisawa A, Kokura A, Yoshikawa T. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochem Biophys Res Commun 1998; 247: 166-170.
16. Hara K, Yamashita S, Fujisawa A, Ogawa T, Yamamoto Y. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids. Biochem Biophys Res Commun 1999; 257: 244-248.
17. Yasuda M, Fujita T. Effect of lipid peroxidation on phospholipase A2 activity of rat livermitochondria. Jpn J Pharmacol 1977; 27: 429-435.
18. Weglicki WB, Dickens BF, Mak IT. Enhanced lysosomal phospholipid degradation and lysophospholipid production due to free radicals. BiochemBiophys Res Commun 1984; 124: 229-235.
19. Beckman JK, Borowitz SM, Burr IM. The role of phospholipase A activity in rat livermicrosomal lipid peroxidation. J Biol Chem 1987; 262: 1479-1481.
20. Gutteridge JMC, Quinlan GJ, Yamamoto Y. Are fatty acid patterns characteristic of essential fatty acid deficiency indicative of oxidative stress? Free Radic Res 1998; 28: 109-114.
21. Quinlan GJ, Lamb NJ, Evans TW, Gutteridge JMC. Plasma fatty acid changes and increased lipid peroxidation in patientswith adult respiratory distress syndrome. Crit CareMed 1996; 24: 241-246.
22. LoveWC, CashellA,ReynoldsM, CallaghanN. Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases. BMJ 1974; 6: 18-21.
23. Battino M, Ferreiro MS, Quiles JL, Bompadre S, Leone L, Bullon P. Alterations in the oxidation products, antioxidant markers, antioxidant capacity and lipid patterns in plasma of patients affected by Papillon-Lefevre syndrome. Free Radic Res 2003; 37: 603-609.
24. Ntambi JM. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 1999; 40: 1549-1558.
25. Ntambi JM. Dietary regulation of stearoyl-CoA desaturase 1 gene expression inmouse liver. J Biol Chem1992; 267: 10925-10930.
26. Weiner FR, Smith PJ, Wertheimer S, Rubin CS. Regulation of gene expression by insulin and tumor necrosis factor alpha in 3T3-L1 cells: modulation of the transcription of genes encoding acyl-CoA synthetase and stearoyl-CoAdesaturase-1. J Biol Chem1991; 266: 23525-23528.
27. Miller CW, Ntambi JM. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 1996; 93: 9443-9448.
28. MillerCW,WatersKM,Ntambi JM.Regulation of hepatic stearoyl-CoA desaturase gene 1 by vitaminA. BiochemBiophysResCommun 1997; 231: 206-210.
29. Sessler AM, Kaur N, Palta JP, Ntambi JM. Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes. J Biol Chem1996; 271: 29854-29858.
30. CohenR,MiyazakiM, SocciNDet al.Role for stearoyl-CoAdesaturase- 1 in leptin-mediated weight loss. Science 2002; 297: 240-243.
31. Ntambi JM, Miyazaki M, Dobrzyn A. Regulation of stearoyl-CoA desaturase expression. Lipids 2004; 39: 1061-1065.